David Guzo

Array ( [id] => 6209134 [patent_doc_number] => 20020072120 [patent_country] => US [patent_kind] => A1 [patent_issue_date] => 2002-06-13 [patent_title] => 'Helper viruses for the preparation of recombinant viral vectors' [patent_app_type] => new [patent_app_number] => 09/920932 [patent_app_country] => US [patent_app_date] => 2001-08-03 [patent_effective_date] => 0000-00-00 [patent_drawing_sheets_cnt] => 8 [patent_figures_cnt] => 8 [patent_no_of_words] => 8297 [patent_no_of_claims] => 24 [patent_no_of_ind_claims] => 10 [patent_words_short_claim] => 13 [patent_maintenance] => 1 [patent_no_of_assignments] => 0 [patent_current_assignee] =>[type] => publication [pdf_file] => publications/A1/0072/20020072120.pdf [firstpage_image] =>[orig_patent_app_number] => 09920932 [rel_patent_id] =>[rel_patent_doc_number] =>)

Array ( [id] => 1281581 [patent_doc_number] => 06642207 [patent_country] => US [patent_kind] => B1 [patent_issue_date] => 2003-11-04 [patent_title] => 'Artificial chromosome constructs containing foreign nucleic acid sequences' [patent_app_type] => B1 [patent_app_number] => 09/922271 [patent_app_country] => US [patent_app_date] => 2001-08-03 [patent_effective_date] => 0000-00-00 [patent_drawing_sheets_cnt] => 3 [patent_figures_cnt] => 5 [patent_no_of_words] => 8455 [patent_no_of_claims] => 8 [patent_no_of_ind_claims] => 3 [patent_words_short_claim] => 37 [patent_maintenance] => 1 [patent_no_of_assignments] => 0 [patent_current_assignee] =>[type] => patent [pdf_file] => patents/06/642/06642207.pdf [firstpage_image] =>[orig_patent_app_number] => 09922271 [rel_patent_id] =>[rel_patent_doc_number] =>)

Array ( [id] => 7394408 [patent_doc_number] => 20040038394 [patent_country] => US [patent_kind] => A1 [patent_issue_date] => 2004-02-26 [patent_title] => 'Expression vector using for animal cell' [patent_app_type] => new [patent_app_number] => 10/343303 [patent_app_country] => US [patent_app_date] => 2003-08-04 [patent_effective_date] => 0000-00-00 [patent_drawing_sheets_cnt] => 16 [patent_figures_cnt] => 16 [patent_no_of_words] => 8895 [patent_no_of_claims] => 8 [patent_no_of_ind_claims] => 3 [patent_words_short_claim] => 37 [patent_maintenance] => 1 [patent_no_of_assignments] => 0 [patent_current_assignee] =>[type] => publication [pdf_file] => publications/A1/0038/20040038394.pdf [firstpage_image] =>[orig_patent_app_number] => 10343303 [rel_patent_id] =>[rel_patent_doc_number] =>)

Array ( [id] => 5905004 [patent_doc_number] => 20020141974 [patent_country] => US [patent_kind] => A1 [patent_issue_date] => 2002-10-03 [patent_title] => 'Hepatitis therapeutics' [patent_app_type] => new [patent_app_number] => 09/912679 [patent_app_country] => US [patent_app_date] => 2001-07-24 [patent_effective_date] => 0000-00-00 [patent_drawing_sheets_cnt] => 17 [patent_figures_cnt] => 17 [patent_no_of_words] => 34015 [patent_no_of_claims] => 24 [patent_no_of_ind_claims] => 12 [patent_words_short_claim] => 14 [patent_maintenance] => 1 [patent_no_of_assignments] => 0 [patent_current_assignee] =>[type] => publication [pdf_file] => publications/A1/0141/20020141974.pdf [firstpage_image] =>[orig_patent_app_number] => 09912679 [rel_patent_id] =>[rel_patent_doc_number] =>)

Array ( [id] => 1241106 [patent_doc_number] => 06682929 [patent_country] => US [patent_kind] => B2 [patent_issue_date] => 2004-01-27 [patent_title] => 'Adenovector complementing cells' [patent_app_type] => B2 [patent_app_number] => 09/910828 [patent_app_country] => US [patent_app_date] => 2001-07-23 [patent_effective_date] => 0000-00-00 [patent_drawing_sheets_cnt] => 0 [patent_figures_cnt] => 0 [patent_no_of_words] => 6212 [patent_no_of_claims] => 14 [patent_no_of_ind_claims] => 2 [patent_words_short_claim] => 81 [patent_maintenance] => 1 [patent_no_of_assignments] => 0 [patent_current_assignee] =>[type] => patent [pdf_file] => patents/06/682/06682929.pdf [firstpage_image] =>[orig_patent_app_number] => 09910828 [rel_patent_id] =>[rel_patent_doc_number] =>)

Array ( [id] => 6774257 [patent_doc_number] => 20030017595 [patent_country] => US [patent_kind] => A1 [patent_issue_date] => 2003-01-23 [patent_title] => 'Non-adenoviral gene product-based complementing cells for adenoviral vectors' [patent_app_type] => new [patent_app_number] => 09/911011 [patent_app_country] => US [patent_app_date] => 2001-07-23 [patent_effective_date] => 0000-00-00 [patent_drawing_sheets_cnt] => 0 [patent_figures_cnt] => 0 [patent_no_of_words] => 8608 [patent_no_of_claims] => 39 [patent_no_of_ind_claims] => 2 [patent_words_short_claim] => 80 [patent_maintenance] => 1 [patent_no_of_assignments] => 0 [patent_current_assignee] =>[type] => publication [pdf_file] => publications/A1/0017/20030017595.pdf [firstpage_image] =>[orig_patent_app_number] => 09911011 [rel_patent_id] =>[rel_patent_doc_number] =>)

Array ( [id] => 6129864 [patent_doc_number] => 20020076814 [patent_country] => US [patent_kind] => A1 [patent_issue_date] => 2002-06-20 [patent_title] => 'Method of using fish plasma components for tissue culture' [patent_app_type] => new [patent_app_number] => 09/907443 [patent_app_country] => US [patent_app_date] => 2001-07-18 [patent_effective_date] => 0000-00-00 [patent_drawing_sheets_cnt] => 6 [patent_figures_cnt] => 6 [patent_no_of_words] => 4320 [patent_no_of_claims] => 20 [patent_no_of_ind_claims] => 1 [patent_words_short_claim] => 76 [patent_maintenance] => 1 [patent_no_of_assignments] => 0 [patent_current_assignee] =>[type] => publication [pdf_file] => publications/A1/0076/20020076814.pdf [firstpage_image] =>[orig_patent_app_number] => 09907443 [rel_patent_id] =>[rel_patent_doc_number] =>)

Array ( [id] => 6224555 [patent_doc_number] => 20020004242 [patent_country] => US [patent_kind] => A1 [patent_issue_date] => 2002-01-10 [patent_title] => 'Plasmids for construction of eukaryotic viral vectors' [patent_app_type] => new [patent_app_number] => 09/905758 [patent_app_country] => US [patent_app_date] => 2001-07-13 [patent_effective_date] => 0000-00-00 [patent_drawing_sheets_cnt] => 8 [patent_figures_cnt] => 8 [patent_no_of_words] => 9304 [patent_no_of_claims] => 30 [patent_no_of_ind_claims] => 16 [patent_words_short_claim] => 19 [patent_maintenance] => 1 [patent_no_of_assignments] => 0 [patent_current_assignee] =>[type] => publication [pdf_file] => publications/A1/0004/20020004242.pdf [firstpage_image] =>[orig_patent_app_number] => 09905758 [rel_patent_id] =>[rel_patent_doc_number] =>)

Array ( [id] => 6468769 [patent_doc_number] => 20020151067 [patent_country] => US [patent_kind] => A1 [patent_issue_date] => 2002-10-17 [patent_title] => 'DNA expression systems based on alphaviruses' [patent_app_type] => new [patent_app_number] => 09/901106 [patent_app_country] => US [patent_app_date] => 2001-07-10 [patent_effective_date] => 0000-00-00 [patent_drawing_sheets_cnt] => 33 [patent_figures_cnt] => 33 [patent_no_of_words] => 14363 [patent_no_of_claims] => 41 [patent_no_of_ind_claims] => 10 [patent_words_short_claim] => 21 [patent_maintenance] => 1 [patent_no_of_assignments] => 0 [patent_current_assignee] =>[type] => publication [pdf_file] => publications/A1/0151/20020151067.pdf [firstpage_image] =>[orig_patent_app_number] => 09901106 [rel_patent_id] =>[rel_patent_doc_number] =>)

Array ( [id] => 5827928 [patent_doc_number] => 20020068046 [patent_country] => US [patent_kind] => A1 [patent_issue_date] => 2002-06-06 [patent_title] => 'Use of stem cells derived from dermal skin' [patent_app_type] => new [patent_app_number] => 09/901786 [patent_app_country] => US [patent_app_date] => 2001-07-09 [patent_effective_date] => 0000-00-00 [patent_drawing_sheets_cnt] => 0 [patent_figures_cnt] => 0 [patent_no_of_words] => 1691 [patent_no_of_claims] => 9 [patent_no_of_ind_claims] => 1 [patent_words_short_claim] => 57 [patent_maintenance] => 1 [patent_no_of_assignments] => 0 [patent_current_assignee] =>[type] => publication [pdf_file] => publications/A1/0068/20020068046.pdf [firstpage_image] =>[orig_patent_app_number] => 09901786 [rel_patent_id] =>[rel_patent_doc_number] =>)

Array ( [id] => 6562364 [patent_doc_number] => 20020164799 [patent_country] => US [patent_kind] => A1 [patent_issue_date] => 2002-11-07 [patent_title] => 'Adenovirus vectors specific for cells expressing alpha-fetoprotein and methods of use thereof' [patent_app_type] => new [patent_app_number] => 09/898883 [patent_app_country] => US [patent_app_date] => 2001-07-02 [patent_effective_date] => 0000-00-00 [patent_drawing_sheets_cnt] => 23 [patent_figures_cnt] => 23 [patent_no_of_words] => 22946 [patent_no_of_claims] => 48 [patent_no_of_ind_claims] => 2 [patent_words_short_claim] => 17 [patent_maintenance] => 1 [patent_no_of_assignments] => 0 [patent_current_assignee] =>[type] => publication [pdf_file] => publications/A1/0164/20020164799.pdf [firstpage_image] =>[orig_patent_app_number] => 09898883 [rel_patent_id] =>[rel_patent_doc_number] =>)

Array ( [id] => 6870122 [patent_doc_number] => 20030082811 [patent_country] => US [patent_kind] => A1 [patent_issue_date] => 2003-05-01 [patent_title] => 'Adenovirus E4 protein variants for virus production' [patent_app_type] => new [patent_app_number] => 09/895940 [patent_app_country] => US [patent_app_date] => 2001-06-29 [patent_effective_date] => 0000-00-00 [patent_drawing_sheets_cnt] => 12 [patent_figures_cnt] => 12 [patent_no_of_words] => 15108 [patent_no_of_claims] => 41 [patent_no_of_ind_claims] => 4 [patent_words_short_claim] => 40 [patent_maintenance] => 1 [patent_no_of_assignments] => 0 [patent_current_assignee] =>[type] => publication [pdf_file] => publications/A1/0082/20030082811.pdf [firstpage_image] =>[orig_patent_app_number] => 09895940 [rel_patent_id] =>[rel_patent_doc_number] =>)

Array ( [id] => 6715895 [patent_doc_number] => 20030027243 [patent_country] => US [patent_kind] => A1 [patent_issue_date] => 2003-02-06 [patent_title] => 'Antifungal compounds and methods of use' [patent_app_type] => new [patent_app_number] => 09/893519 [patent_app_country] => US [patent_app_date] => 2001-06-28 [patent_effective_date] => 0000-00-00 [patent_drawing_sheets_cnt] => 174 [patent_figures_cnt] => 174 [patent_no_of_words] => 31323 [patent_no_of_claims] => 29 [patent_no_of_ind_claims] => 8 [patent_words_short_claim] => 89 [patent_maintenance] => 1 [patent_no_of_assignments] => 0 [patent_current_assignee] =>[type] => publication [pdf_file] => publications/A1/0027/20030027243.pdf [firstpage_image] =>[orig_patent_app_number] => 09893519 [rel_patent_id] =>[rel_patent_doc_number] =>)

Array ( [id] => 1062711 [patent_doc_number] => 06849455 [patent_country] => US [patent_kind] => B1 [patent_issue_date] => 2005-02-01 [patent_title] => 'Enhanced recovery of transformed cells' [patent_app_type] => utility [patent_app_number] => 09/888373 [patent_app_country] => US [patent_app_date] => 2001-06-26 [patent_effective_date] => 0000-00-00 [patent_drawing_sheets_cnt] => 6 [patent_figures_cnt] => 17 [patent_no_of_words] => 14949 [patent_no_of_claims] => 10 [patent_no_of_ind_claims] => 2 [patent_words_short_claim] => 30 [patent_maintenance] => 1 [patent_no_of_assignments] => 0 [patent_current_assignee] =>[type] => patent [pdf_file] => patents/06/849/06849455.pdf [firstpage_image] =>[orig_patent_app_number] => 09888373 [rel_patent_id] =>[rel_patent_doc_number] =>)

Array ( [id] => 1292567 [patent_doc_number] => 06630585 [patent_country] => US [patent_kind] => B2 [patent_issue_date] => 2003-10-07 [patent_title] => 'Method for purifying nucleic acids from feces' [patent_app_type] => B2 [patent_app_number] => 09/883378 [patent_app_country] => US [patent_app_date] => 2001-06-19 [patent_effective_date] => 0000-00-00 [patent_drawing_sheets_cnt] => 3 [patent_figures_cnt] => 3 [patent_no_of_words] => 2089 [patent_no_of_claims] => 18 [patent_no_of_ind_claims] => 4 [patent_words_short_claim] => 34 [patent_maintenance] => 1 [patent_no_of_assignments] => 0 [patent_current_assignee] =>[type] => patent [pdf_file] => patents/06/630/06630585.pdf [firstpage_image] =>[orig_patent_app_number] => 09883378 [rel_patent_id] =>[rel_patent_doc_number] =>)

Array ( [id] => 6749872 [patent_doc_number] => 20030044392 [patent_country] => US [patent_kind] => A1 [patent_issue_date] => 2003-03-06 [patent_title] => 'Human PEA3 is a tumor suppressor for cancer cells' [patent_app_type] => new [patent_app_number] => 09/884363 [patent_app_country] => US [patent_app_date] => 2001-06-18 [patent_effective_date] => 0000-00-00 [patent_drawing_sheets_cnt] => 5 [patent_figures_cnt] => 5 [patent_no_of_words] => 24371 [patent_no_of_claims] => 30 [patent_no_of_ind_claims] => 3 [patent_words_short_claim] => 25 [patent_maintenance] => 1 [patent_no_of_assignments] => 0 [patent_current_assignee] =>[type] => publication [pdf_file] => publications/A1/0044/20030044392.pdf [firstpage_image] =>[orig_patent_app_number] => 09884363 [rel_patent_id] =>[rel_patent_doc_number] =>)

Array ( [id] => 6142175 [patent_doc_number] => 20020002131 [patent_country] => US [patent_kind] => A1 [patent_issue_date] => 2002-01-03 [patent_title] => 'Methods and compositions for inhibiting angiogenesis' [patent_app_type] => new [patent_app_number] => 09/875114 [patent_app_country] => US [patent_app_date] => 2001-06-06 [patent_effective_date] => 0000-00-00 [patent_drawing_sheets_cnt] => 7 [patent_figures_cnt] => 7 [patent_no_of_words] => 6283 [patent_no_of_claims] => 25 [patent_no_of_ind_claims] => 6 [patent_words_short_claim] => 13 [patent_maintenance] => 1 [patent_no_of_assignments] => 0 [patent_current_assignee] =>[type] => publication [pdf_file] => publications/A1/0002/20020002131.pdf [firstpage_image] =>[orig_patent_app_number] => 09875114 [rel_patent_id] =>[rel_patent_doc_number] =>)

Array ( [id] => 1034401 [patent_doc_number] => 06875610 [patent_country] => US [patent_kind] => B2 [patent_issue_date] => 2005-04-05 [patent_title] => 'Methods and compositions for efficient gene transfer using transcomplementary vectors' [patent_app_type] => utility [patent_app_number] => 09/871183 [patent_app_country] => US [patent_app_date] => 2001-05-31 [patent_effective_date] => 0000-00-00 [patent_drawing_sheets_cnt] => 25 [patent_figures_cnt] => 30 [patent_no_of_words] => 16430 [patent_no_of_claims] => 8 [patent_no_of_ind_claims] => 2 [patent_words_short_claim] => 17 [patent_maintenance] => 1 [patent_no_of_assignments] => 0 [patent_current_assignee] =>[type] => patent [pdf_file] => patents/06/875/06875610.pdf [firstpage_image] =>[orig_patent_app_number] => 09871183 [rel_patent_id] =>[rel_patent_doc_number] =>)

Array ( [id] => 6986818 [patent_doc_number] => 20010036650 [patent_country] => US [patent_kind] => A1 [patent_issue_date] => 2001-11-01 [patent_title] => 'C5a receptor' [patent_app_type] => new [patent_app_number] => 09/867569 [patent_app_country] => US [patent_app_date] => 2001-05-31 [patent_effective_date] => 0000-00-00 [patent_drawing_sheets_cnt] => 9 [patent_figures_cnt] => 9 [patent_no_of_words] => 12726 [patent_no_of_claims] => 53 [patent_no_of_ind_claims] => 7 [patent_words_short_claim] => 36 [patent_maintenance] => 1 [patent_no_of_assignments] => 0 [patent_current_assignee] =>[type] => publication [pdf_file] => publications/A1/0036/20010036650.pdf [firstpage_image] =>[orig_patent_app_number] => 09867569 [rel_patent_id] =>[rel_patent_doc_number] =>)

Array ( [id] => 637351 [patent_doc_number] => 07125549 [patent_country] => US [patent_kind] => B2 [patent_issue_date] => 2006-10-24 [patent_title] => 'Methods and compositions for efficient gene transfer using transcomplementary vectors' [patent_app_type] => utility [patent_app_number] => 10/297099 [patent_app_country] => US [patent_app_date] => 2001-05-31 [patent_effective_date] => 0000-00-00 [patent_drawing_sheets_cnt] => 27 [patent_figures_cnt] => 27 [patent_no_of_words] => 14266 [patent_no_of_claims] => 8 [patent_no_of_ind_claims] => 4 [patent_words_short_claim] => 32 [patent_maintenance] => 1 [patent_no_of_assignments] => 0 [patent_current_assignee] =>[type] => patent [pdf_file] => patents/07/125/07125549.pdf [firstpage_image] =>[orig_patent_app_number] => 10297099 [rel_patent_id] =>[rel_patent_doc_number] =>)